Kenvue Inc. (NYSE:KVUE) Shares Sold by Great Valley Advisor Group Inc.

Great Valley Advisor Group Inc. trimmed its holdings in Kenvue Inc. (NYSE:KVUE) by 3.8% during the third quarter, HoldingsChannel.com reports. The firm owned 14,395 shares of the company’s stock after selling 568 shares during the period. Great Valley Advisor Group Inc.’s holdings in Kenvue were worth $333,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in KVUE. Riverview Trust Co acquired a new position in shares of Kenvue in the 3rd quarter valued at approximately $30,000. Ashton Thomas Securities LLC acquired a new position in shares of Kenvue in the 3rd quarter valued at approximately $35,000. Studio Investment Management LLC raised its position in shares of Kenvue by 52.1% in the 2nd quarter. Studio Investment Management LLC now owns 2,468 shares of the company’s stock valued at $45,000 after purchasing an additional 845 shares in the last quarter. Deseret Mutual Benefit Administrators raised its position in shares of Kenvue by 49.7% in the 3rd quarter. Deseret Mutual Benefit Administrators now owns 1,960 shares of the company’s stock valued at $45,000 after purchasing an additional 651 shares in the last quarter. Finally, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in shares of Kenvue in the 2nd quarter valued at approximately $61,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. Royal Bank of Canada lowered Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price target on the stock. in a research report on Tuesday, September 24th. Bank of America upped their price target on Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Tuesday, October 22nd. JPMorgan Chase & Co. upped their price target on Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Piper Sandler upped their price target on Kenvue from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Monday, September 23rd. Finally, Jefferies Financial Group assumed coverage on Kenvue in a research report on Tuesday, September 24th. They set a “buy” rating and a $27.00 price target on the stock. One analyst has rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $22.64.

Kenvue Stock Performance

Shares of Kenvue stock opened at $24.12 on Thursday. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. The firm has a market cap of $46.24 billion, a price-to-earnings ratio of 43.85, a price-to-earnings-growth ratio of 2.20 and a beta of 1.36. The business has a fifty day simple moving average of $22.89 and a 200-day simple moving average of $20.94. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $24.46.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.01. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. The business had revenue of $3.90 billion during the quarter, compared to analyst estimates of $3.92 billion. During the same quarter in the prior year, the firm posted $0.31 earnings per share. The company’s revenue was down .4% on a year-over-year basis. On average, equities analysts forecast that Kenvue Inc. will post 1.07 EPS for the current fiscal year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, November 27th. Stockholders of record on Wednesday, November 13th were issued a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a dividend yield of 3.40%. The ex-dividend date was Wednesday, November 13th. Kenvue’s dividend payout ratio is 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.